Anthropic lists Trump's "retaliation risk" in the IPO documents, with AI safety stance becoming the focus

According to Bloomberg, Anthropic warned in its IPO-related documents that its public advocacy for AI safety regulation and statements from executives may expose the company to risks such as pressure from the Trump administration and selective scrutiny. This risk is related to the company's multiple conflicts with the Trump administration, including disputes over requests to impose safety restrictions on the use of its AI technology by the Department of Defense, as well as disagreements regarding the safety of the Mythos model and export controls.

Anthropic also warned that even if other similarly situated companies are not treated equally, Anthropic may still become a specific target for certain departments of the Trump administration. Future export restrictions and cybersecurity or biosafety incidents triggered by AI models could impact its product deployment, international expansion, and business growth.

The company also acknowledged that once the regulatory measures it advocates are implemented, they may increase compliance costs, restrict product development and release, and slow its own growth.